![Susannah Gray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susannah Gray
Presidente presso
THERAVANCE BIOPHARMA, INC.
Patrimonio netto: 271 M $ in data 30/06/2026
Profilo
Susannah Gray is currently Chairman at Theravance Biopharma, Inc. since 2024.
Current roles also include Director positions at The German Marshall Fund of United States, StreetSquash, Biosplice Therapeutics, Inc., Susan G.
Komen Foundation, Biosplice LLC, Colby College Museum of Art, and Wesleyan University as Trustee.
Independent Director at 4D Molecular Therapeutics, Inc. since 2020, Maravai Lifesciences Holdings, Inc. since 2020, and AnaptysBio, Inc. starting 2026.
Director at Morphic Therapeutic, Inc. since 2021 and Maravai Life Sciences, Inc. since 2020.
Former roles include Managing Director at Merrill Lynch & Co., Inc., Director at Susan G.
Komen for the Cure from 2019 to 2022, Independent Director at Apria, Inc. from 2021 to 2022, Independent Director at Morphic Holding, Inc. from 2021 to 2024, Analyst at CIBC World Markets Corp.
from 2002 to 2004, Executive Vice President-Finance & Strategy at RP Management LLC in 2019, and Executive Vice President-Finance & Strategy at Royalty Pharma Management LLC from 2018 to 2019.
Education includes an undergraduate degree from Wesleyan University in 1982 and an MBA from Columbia Business School in 1990.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
RPI US Partners 2019 LP
 RPI US Partners 2019 LP Financial ConglomeratesFinance Functions as an investment fund 2,24% | 16/06/2020 | 4.788.526 ( 2,24% ) | 268 M $ | 30/06/2026 |
| 26/05/2026 | 216.200 ( 0,15% ) | 1 M $ | 30/06/2026 | |
| 12/06/2026 | 48.146 ( 0,09% ) | 818 482 $ | 30/06/2026 | |
| 17/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Posizioni attive di Susannah Gray
| Società | Posizione | Inizio |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/07/2020 |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Direttore/Membro del Consiglio | 01/11/2020 |
| THERAVANCE BIOPHARMA, INC. | Presidente | 12/11/2024 |
| ANAPTYSBIO, INC. | Direttore/Membro del Consiglio | 26/03/2026 |
Biosplice Therapeutics, Inc.
 Biosplice Therapeutics, Inc. BiotechnologyHealth Technology Operates as a pre-clinical research company that develops small-molecule therapeutics for osteoarthritis & cancer | Direttore/Membro del Consiglio | - |
Maravai Life Sciences, Inc.
 Maravai Life Sciences, Inc. Financial ConglomeratesFinance Provides investment services | Direttore/Membro del Consiglio | 01/12/2020 |
Biosplice LLC | Direttore/Membro del Consiglio | - |
The German Marshall Fund of United States
 The German Marshall Fund of United States Miscellaneous Commercial ServicesCommercial Services Provides public policy think tank and grant making services | Direttore/Membro del Consiglio | - |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | - |
| ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░ ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Precedenti posizioni note di Susannah Gray
| Società | Posizione | Fine |
|---|---|---|
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░ ░░░░░ ░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Susannah Gray
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
72
Relazioni di 1° grado
20
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 20 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
 Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
CIBC World Markets Corp. (Old)
 CIBC World Markets Corp. (Old) Financial ConglomeratesFinance Provides financial services | Finance |
The German Marshall Fund of United States
The German Marshall Fund of United States Miscellaneous Commercial ServicesCommercial Services Provides public policy think tank and grant making services | Commercial Services |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Wesleyan University
Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
StreetSquash
 StreetSquash Services to the Health IndustryHealth Services Provides long-term services for children and families | Health Services |
Susan G. Komen for the Cure
 Susan G. Komen for the Cure Miscellaneous Commercial ServicesCommercial Services Conducts research for breast cancer treatment | Commercial Services |
RP Management LLC
 RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services | Finance |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
Biosplice Therapeutics, Inc.
Biosplice Therapeutics, Inc. BiotechnologyHealth Technology Operates as a pre-clinical research company that develops small-molecule therapeutics for osteoarthritis & cancer | Health Technology |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Susan G. Komen Foundation | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Maravai Lifesciences Holdings, Inc.
 Maravai Lifesciences Holdings, Inc. BiotechnologyHealth Technology Develops and sells drug therapies, diagnostics and novel vaccines | Health Technology |
Apria, Inc.
 Apria, Inc. Medical/Nursing ServicesHealth Services Provides home healthcare services | Health Services |
Royalty Pharma Management LLC
 Royalty Pharma Management LLC Financial ConglomeratesFinance Engages in funding in biopharmaceutical industry | Finance |
Biosplice LLC |
